388
ADVANCED IMAGING OF THE ABDOMEN
A B
|
|
Figure 7.43. Metastatic pancreatic |
carcinoma. A: Transverse |
|
|
|
pulse-inversion harmonic US reveals multiple tumors with varying |
||
|
|
echogenicity. B: Similar contrast-enhanced US 27 seconds after |
||
|
|
contrast injection reveals an initial rim enhancement (arrows), |
||
|
|
with tumors becoming hypoechoic 55 seconds after injection (C). |
||
|
|
(Source: Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. |
||
|
|
Hepatic tumors: contrast agent-enhancement patterns with |
||
|
|
pulse-inversion harmonic US. Radiology 2000;216:411–417, with |
||
C |
|
permission from the Radiological Society of North America.) |
|
|
heterogeneous signal intensity, an irregular |
enhanced MR also detects metastases. Never- |
|||
margin, or a surrounding high signal intensity |
theless, compared to eventual pathological |
|||
ring (halo). This is in distinction to heman- |
study, even contrast enhanced MRI misses some |
|||
giomas and cysts, which tend to be more homo- |
tumors. Preand serial postcontrast images |
|||
geneous, contain well-defined margins, and |
provide most information. |
|
|
|
have a very high signal intensity on T2-weighted |
The role of MR arterial portography is still |
|||
images. |
|
evolving. Preliminary results using a turbo |
||
Most studies suggest that gadolinium- |
FLASH MR technique suggest that tumors >10 |
|||
enhanced MRI detects more metastases than |
mm can be detected. |
|
|
|
unenhanced MRI. Most hypovascular metas- |
Somatostatin-receptor scintigraphy is useful |
|||
tases are best defined on portal venous phase |
for suspected endocrine metastases. |
|
||
imaging when maximum enhancement of |
Fluoro-deoxy-D-glucose |
(FDG)-PET |
is |
|
normal liver parenchyma occurs. On immediate |
evolving into a viable imaging modality for |
|||
postcontrast images these metastases tend to |
detecting liver metastases. Both adenocarcino- |
|||
mimic cysts, but delayed views reveal gradual |
mas and sarcomas reveal increased uptake. |
|||
contrast enhancement and an apparent de- |
Preliminary evidence suggests that it rivals |
|||
crease in tumor size, findings not evident with |
CT in accuracy. One should keep in mind, |
|||
cysts. |
|
however, that increased uptake also occurs in |
||
Most metastases |
have a marked increase |
some abscesses. |
|
|
in lesion-to-liver contrast on ferumoxides- |
Radioimmunoscintigraphy with Tc-99m– |
|||
enhanced T2-weighted images (81) and this |
labeled anti-CEA monoclonal antibody reveals |
|||
technique detects more metastatic nodules than |
uptake in some liver metastases. This study |
|||
nonenhanced MR. |
Similarly, mangafodipir |
appears most useful with a rising CEA level. |
|
|